Latest news with #JohnRansom
CNBC
6 days ago
- Health
- CNBC
UnitedHealth's stock doesn't offer much value, says Raymond James' John Ransom
Jeff Jonas, Gabelli portfolio manager, and John Ransom, Raymond James director of healthcare research, join 'Power Lunch' to discuss each expert's thoughts on UnitedHealth amid its recent plunge.
Business Insider
19-07-2025
- Business
- Business Insider
Humana (HUM) Gets a Buy from Raymond James
In a report released today, John Ransom from Raymond James reiterated a Buy rating on Humana, with a price target of $340.00. The company's shares opened today at $222.95. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Ransom is a 5-star analyst with an average return of 8.5% and a 57.23% success rate. Ransom covers the Healthcare sector, focusing on stocks such as Humana, Encompass Health, and UnitedHealth. In addition to Raymond James, Humana also received a Buy from Mizuho Securities's Ann Hynes in a report issued today. However, on the same day, Morgan Stanley maintained a Hold rating on Humana (NYSE: HUM).
Business Insider
03-06-2025
- Business
- Business Insider
TD Cowen Remains a Hold on UnitedHealth (UNH)
In a report released today, Ryan Langston from TD Cowen reiterated a Hold rating on UnitedHealth (UNH – Research Report), with a price target of $308.00. Confident Investing Starts Here: Langston covers the Healthcare sector, focusing on stocks such as UnitedHealth, P3 Health Partners, and Acadia Healthcare. According to TipRanks, Langston has an average return of -7.2% and a 30.56% success rate on recommended stocks. In addition to TD Cowen, UnitedHealth also received a Hold from Raymond James's John Ransom in a report issued on May 16. However, today, KeyBanc maintained a Buy rating on UnitedHealth (NYSE: UNH). Based on UnitedHealth's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $109.58 billion and a net profit of $6.29 billion. In comparison, last year the company earned a revenue of $98.79 billion and had a GAAP net loss of $1.41 billion Based on the recent corporate insider activity of 147 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of UNH in relation to earlier this year. Last month, Timothy Patrick Flynn, a Director at UNH bought 1,533.00 shares for a total of $491,786.40.
CNBC
14-05-2025
- Health
- CNBC
Raymond James' John Ransom: UnitedHealth will now trade closer to an industry multiple
John Ransom, Raymond James director of healthcare research, joins 'Power Lunch' to discuss why Ransom has pause on shares of UnitedHealth, why the company withdrew its guidance, and much more.
